| http://www.w3.org/ns/prov#value | - Agent: Novozymes North America, Inc.20090137483 - Antagonists of the bradykinin b1 receptor: The present invention relates to composition of matter involving bradykinin B1 receptor antagonist peptides conjugated to a univalent vehicle, including peptides conjugated to univalent PEG. These compositions can be used as therapeutics or prophylactics against diseases or conditions, such as inflammation
|
